Call our 24 hours, seven days a week helpline at 800.272.3900
Let us connect you to professionals and support options near you. Please select an option below:
Use Current LocationUse Map Selector
Celebrate the holidays with a year-end gift that can go 3x as far to help provide care and support to people affected by Alzheimer’s disease, and to advance critical research. But please hurry — this 3x Match Challenge ends soon.
There's no cure for Alzheimer’s, but there are treatments that may change disease progression, and drug and non-drug options that may help treat symptoms. Understanding available options can help individuals living with the disease and their caregivers to cope with symptoms and improve quality of life.
Progress in Alzheimer's research has created promising new treatments. Learn about the different drugs so you can discuss the options with a doctor.
The first FDA-approved therapy to address the underlying biology of Alzheimer’s disease has been discontinued.
Donanemab (Kisunla™) has received traditional approval from the U.S. Food and Drug Administration (FDA) to treat early Alzheimer's disease.
Lecanemab (Leqembi™) has received accelerated approval as a treatment for early Alzheimer’s from the U.S. Food and Drug Administration (FDA).
CMS has released more details about its plan to cover FDA-approved drugs, including donanemab (Kisunla) and lecanemab (Leqembi), for Alzheimer’s disease.
Although current medications cannot cure Alzheimer’s, one treatment addresses the underlying biology. Other medications may help lessen symptoms.
Learn about alternative treatments and the current scientific findings about them.
Donate Now
Take the Brain Tour
Learn More